Search For "subject expert committee"
Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on chi
Updated : 5 years ago IST
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
Read More
Russia's Sputnik V gets Emergency Use Authorisation nod in India
Updated : 5 years, 1 month ago IST
New Delhi [India], April 12 (ANI): Russia's Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.
Read More
Expert panel likely to take call on Sputnik V vaccine at key meet today
Updated : 5 years, 1 month ago IST
New Delhi [India], April 12 (ANI): The Subject Expert Committee (SEC) is likely to meet today to take up Sputnik V application for Emergency Use Authorisation (EUA) in India, said sources.
Read More
Expert Committte demands additional information from Sputnik V on EUA in I
Updated : 5 years, 1 month ago IST
New Delhi [India], April 1 (ANI): Russia's COVID-19 Sputnik V vaccine was denied emergency use authorisation in India on Thursday by the Subject Expert Committee (SEC) constituted by the central government.
Read More
COVID-19: India to decide emergency use authorisation of Sputnik V vaccine
Updated : 5 years, 1 month ago IST
New Delhi [India], March 31 (ANI): Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to deliberate on emergency use authorisation application of Russian vaccine Sputnik V.
Read More
SEC recommends authorisation to Covaxin without 'clinical trial mode'
Updated : 5 years, 2 months ago IST
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Read More
SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V C
Updated : 5 years, 3 months ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) has recommended additional immunogenicity data from Dr Reddy's Laboratories which applied to the national drugs regulator seeking emergency use approval for Sputnik
Read More
SEC to discuss Dr Reddy's application for emergency use of Sputnik V vacci
Updated : 5 years, 3 months ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) is going to meet on Wednesday afternoon to discuss Dr Reddy's Laboratories application seeking emergency use approval (EUA) for SputnikV, a Russian Vaccine.
Read More
Pfizer showed no plans to generate safety data in Indian population for CO
Updated : 5 years, 3 months ago IST
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu
Read More
Andhra govt revises conventional UG programmes under NEP
Updated : 5 years, 4 months ago IST
Amaravati (Andhra Pradesh) [India], January 6 (ANI): Andhra Pradesh Education Minister Adimulapu Suresh on Tuesday said that outcome-based curriculum of conventional undergraduate programs was revised through subject expert committees under National Education Policy (NEP).
Read More
DCGI to brief media today on COVID-19 vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
Read More
COVID-19: Expert committee recommends restricted emergency use of SII, Bha
Updated : 5 years, 4 months ago IST
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.
Read More